How to check a research peptide supplier's documentation before you order

Research peptide supplier documentation is the only objective signal available to a buyer who cannot inspect the compound directly. When you order a vial of semaglutide or BPC-157 for laboratory work, you cannot assess purity by sight, confirm molecular identity by taste, or verify peptide content without a mass spectrometer. What you can do, before you place the order, is examine the certificates of analysis, batch records, and supplier data that a vendor publishes. That examination takes twenty minutes. Skipping it saves twenty minutes. Whether that trade is worth it depends on how much your research outcomes depend on working with a compound that matches its label.

This guide explains what documentation to request, how to read it, what the gaps reveal, and what a supplier's willingness to share data says about their quality systems. It is written for buyers who have some familiarity with peptide chemistry but who may not have encountered the documentation conventions of this particular market before.

What a certificate of analysis should contain

A certificate of analysis is a document issued by an analytical laboratory confirming the results of specific tests performed on a specific sample. In the peptide research market, the minimum a useful COA should include is: the peptide compound name and sequence, a batch or lot number, the testing date, the name and location of the laboratory, the analytical method used (HPLC for purity, mass spectrometry for molecular identity), and the numerical results of those tests. If any of those six elements are absent, the COA is incomplete. You can request a full version from the supplier, and the response to that request tells you almost as much as the document itself.

HPLC purity is the figure most commonly cited. It measures what proportion of the sample consists of the target peptide, as opposed to synthesis by-products, truncated sequences, or unrelated contaminants. For research-grade peptides, 98% purity or above is the conventional standard, though certain difficult sequences can legitimately come in at 95–97%. The number alone is not enough. The HPLC chromatogram, the graph showing compound separation over time, should accompany it. A well-synthesised peptide produces a dominant peak that is cleanly separated from any minor peaks. A messy chromatogram with multiple significant peaks, or a chromatogram that is not provided at all, warrants a question to the supplier before you order.

Mass spectrometry confirms molecular identity. Each peptide sequence has a theoretical molecular weight determined by the sum of its amino acids. The MS result should match that theoretical mass within a small margin (typically plus or minus two to five daltons). If the measured mass is significantly off, the peptide may be missing one or more amino acids, contain a substitution, or be an entirely different compound. Purity alone does not confirm identity: a sample could be 99% pure and still not be what the label says, if what it is 99% pure of is the wrong molecule. Both HPLC and MS together give you meaningful confidence; HPLC alone does not.

Peptide content is a third metric that fewer suppliers report, but it matters for practical dosing. A vial labelled 10 mg might contain 8.5 mg of actual peptide and 1.5 mg of excipient, typically mannitol added to increase vial mass and protect the compound during lyophilisation. If the peptide content is 85%, your starting mass for any reconstitution calculation is 8.5 mg, not 10 mg. If the COA does not state peptide content, ask. The answer will tell you whether the supplier knows the figure, whether they think it is relevant, and whether they have tested for it. A supplier who cannot answer that question has either not measured peptide content or does not understand why it matters.

How to verify batch-specific documentation

A COA that cannot be traced to a specific batch is worth little. It may be a genuine document produced for a different lot, a copied certificate modified to cover an untested production run, or a document fabricated entirely. The batch or lot number on the COA should match the identifier printed on the label of the vial you are receiving. If a supplier publishes product-level COAs rather than batch-specific ones, one document for an entire product line rather than one document per production run, the verification value drops considerably. You are looking at evidence that one batch of that compound was tested, not that yours was.

To check this yourself: before you order, download the COA from the product page and note the lot number. When your order arrives, compare that number to the label on the vial. If they do not match, contact the supplier. A competent supplier will either provide the correct COA for your lot or explain the discrepancy. A supplier who cannot match a COA to a vial has either issued a generic document or does not track their own batch records, neither of which reflects well on the quality system behind the product.

One cross-check that costs nothing: look the laboratory up. The lab name should be on the COA. A legitimate analytical laboratory has a public presence, an address, contact details, and in most cases an accreditation (ISO 17025 is the relevant standard for testing and calibration laboratories). If you cannot find the laboratory with a straightforward search, or if the name appears only in documents from that one supplier, that is a flag. Not proof of anything by itself, but worth noting alongside the other things you find.

Three patterns that suggest a supplier is not testing what they sell

The first is identical results across multiple batches. Synthesis quality varies. Reagent lots differ, reaction conditions fluctuate, and the purity of any given production run reflects those small variations. If a supplier lists the same purity figure for ten consecutive batches of the same compound, for example 98.5% across every lot, the consistency itself becomes implausible. Independent testing would be expected to show at least some variation between runs. Identical figures across batches may indicate that a single COA is being recycled, with only the lot number changed. You can test this by downloading COAs for several different batches of the same product and comparing them carefully, including the testing date, the chromatogram shape, and the retention time values if they are included.

The second pattern is a refusal to provide COAs for a specific lot you are about to purchase. Some suppliers publish representative COAs and provide lot-specific documents on request. That is an acceptable arrangement. A supplier who will not provide the COA for the exact lot they are shipping you, or who says the COA is available only after purchase, has removed the main point of the document. The COA exists so you can evaluate the compound before you order it. Post-purchase documentation is a returns policy, not a quality guarantee.

The third is vague or incomplete laboratory identification. If the COA names a laboratory with no searchable public presence, uses only an acronym that does not resolve to a findable entity, or omits the lab name entirely and substitutes something like "internal quality testing," the provenance of the test results is unverifiable. You cannot confirm that the test was conducted by an independent party, what methods were used, or whether the laboratory is accredited to conduct the relevant analyses.

What documentation does not tell you

A COA issued at the point of synthesis does not tell you anything about how the compound was stored or transported between the laboratory and your address. Peptides vary in their stability. Some are stable at room temperature for extended periods in lyophilised form. Others degrade significantly if exposed to moisture, light, or temperature fluctuations above a certain threshold. A vial that tested at 98% purity at the point of synthesis may be at a lower purity by the time it reaches you, if the storage or shipping conditions were inappropriate. This is a limitation that honest documentation practices acknowledge but cannot resolve: a COA is a point-in-time measurement, not a guarantee of the condition of the compound at delivery.

What you can reasonably ask for, in addition to the COA, is the supplier's stated storage and shipping protocols. Do they ship cold? What packaging do they use? What is their advice for storing the compound once you receive it? A supplier who has thought about these questions will answer them specifically. A supplier who responds with generic language about "premium quality" or "industry-leading standards" has probably not thought about them carefully.

Questions to ask before you order

What is the batch number for the stock I will be receiving?

A specific answer confirms that the supplier tracks their inventory at batch level. A vague answer or a statement that the batch varies by fulfilment date suggests they do not match COAs to specific lots.

Can you provide the COA for that specific batch before I complete the order?

A supplier who will not or cannot provide pre-purchase COA for a named lot is asking you to trust the label rather than verify the contents. That may be an acceptable risk depending on your research context, but it is a risk you should go into with your eyes open.

Is the laboratory listed on your COA ISO 17025 accredited?

ISO 17025 accreditation means the laboratory has been assessed by an independent body against a defined standard for testing and calibration. It is not a guarantee that every result the lab produces is correct, but it confirms that the lab has established processes for quality control. Some excellent analytical facilities are not accredited under this standard; accreditation is a useful signal but not the only one.

Does your COA report peptide content, or total vial mass?

The answer determines how you interpret the labelled weight for your dosing calculations. If the supplier does not understand the question, that is itself informative.

What are your cold-chain protocols for temperature-sensitive compounds?

Different peptides have different stability profiles, and a supplier who ships temperature-sensitive compounds without appropriate cold packing either does not know the compound's stability requirements or has decided that the cost of cold-chain shipping is not worth protecting the product. Either conclusion is worth knowing before you order.

One limitation worth stating plainly

Even rigorous pre-purchase documentation review does not eliminate the possibility that the compound you receive will not behave as expected in your research. Storage variability after delivery, reconstitution technique, buffer compatibility, and the specific biological system you are working with all affect experimental outcomes in ways that no COA can predict. Documentation tells you what the compound is. It does not tell you how it will perform in your particular assay. A supplier who implies otherwise is overpromising. The honest position is that verified documentation reduces uncertainty, which is a meaningful improvement over unverified documentation, but it does not eliminate it.

Common questions about supplier documentation

Is a COA with only HPLC purity sufficient?

For many research applications, yes. HPLC purity is the core metric and confirms that the compound is predominantly what it claims to be. For applications where molecular identity is critical, or where you are working with closely related peptide sequences that could be confused, mass spectrometry adds a layer of confirmation that HPLC alone cannot provide. A COA with HPLC only is not automatically suspect, but knowing which analyses are included and what they confirm or leave open is part of evaluating the document.

What should I do if the lot number on my vial does not match the COA on the product page?

Contact the supplier before opening the vial. Ask them to provide the COA for the lot number on your label. Keep a record of your enquiry and their response. If they cannot match the COA to your lot within a reasonable timeframe, that is relevant information for whether you continue using that supplier.

Can I request independent third-party testing for a compound I have already received?

Yes. Several analytical laboratories accept samples from individual buyers for HPLC and MS analysis. The cost is typically significant relative to the cost of a research-grade peptide vial, so this approach is most practical if you are ordering large quantities from a new supplier, or if something about the compound's behaviour in reconstitution or in your assay raises a question worth investigating. It is also an option if a supplier is unable to provide satisfactory batch-specific documentation.

Does an impressive-looking COA with a well-designed layout guarantee the results are genuine?

No. The formatting of a COA reflects the laboratory's document template, not the validity of the results. What matters is the substance of the document: the laboratory name, the analytical method, the result values, and whether those results can be traced to the specific batch you are ordering. A plain, clearly labelled document from a verifiable laboratory is more useful than a polished-looking one from an unidentifiable source.

What is the practical difference between a batch COA and a product COA?

A product COA documents testing done on one production run of a given compound and is presented as representative for all stock of that product. A batch COA documents a specific production run identified by a unique lot number that should correspond to a specific set of vials. If the batch number on a product COA does not match the lot number on your vial, the document cannot tell you anything specific about what is in the vial you received.

Titeris publishes batch-specific COAs for every compound we stock, with the lot number that appears on the vial label. We believe this is the minimum standard for research-grade documentation, not a premium offering. Buyers should expect it, and suppliers who cannot provide it should be asked why not. The answer will tell you most of what you need to know about how seriously that supplier takes the compounds they sell.

Research use only. Not for human or veterinary consumption. All compounds sold by Titeris are intended exclusively for laboratory research by qualified researchers. They are not medicines, supplements, or food products. They are not intended to diagnose, treat, cure, or prevent any disease or medical condition, and they have not been evaluated by the Medicines and Healthcare products Regulatory Agency (MHRA). Purchase is restricted to persons aged 18 and over. Buyers are responsible for ensuring that their use of these compounds complies with all applicable laws and institutional regulations in their jurisdiction.